DR. BOBAK ROBERT MOZAYENI, M.D.
Osteopathic Medicine in Rockville, MD

License number
Maryland D42423
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
6000 Executive Blvd Suite #304, Rockville, MD 20852
Phone
(240) 221-0000
(240) 221-0441 (Fax)

Personal information

See more information about BOBAK ROBERT MOZAYENI at radaris.com
Name
Address
Phone
Bobak R Mozayeni, age 63
11412 Luxmanor Rd, Rockville, MD 20852
(240) 221-0000
Bobak R Mozayeni, age 63
5530 Wisconsin Ave, Chevy Chase, MD 20815
Bobak R Mozayeni, age 63
9715 Medical Center Dr, Rockville, MD 20850

Professional information

Bobak R Mozayeni Photo 1

Dr. Bobak R Mozayeni, Rockville MD - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
Translational Medicine Group
15235 Shady Grove Rd, Rockville 20850
(240) 221-0000 (Phone), (240) 221-0441 (Fax)
Conditions:
Antiphospholipid Syndrome (APS), Lyme Disease
Certifications:
Internal Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albany Medical College
Graduated: 1987
Yale New Haven Hospital
Natl Inst Hlth
Yale University School Of Medicine


Bobak Robert Mozayeni Photo 2

Bobak Robert Mozayeni, North Bethesda MD

Specialties:
Internist
Address:
6000 Executive Blvd, North Bethesda, MD 20852
Education:
Albany Medical College - Doctor of Medicine
National Institutes of Health-Clinical Center - Fellowship - Rheumatology (Internal Medicine)
Yale New Haven Psychiatric Hospital - Fellowship - Rheumatology (Internal Medicine)
Yale New Haven Psychiatric Hospital - Residency - Internal Medicine
Yale New Haven Psychiatric Hospital - Internship - Internal Medicine


Bobak Mozayeni Photo 3

Apparatus And Process For Continuous In Vitro Synthesis Of Proteins

US Patent:
5434079, Jul 18, 1995
Filed:
Feb 12, 1993
Appl. No.:
8/017062
Inventors:
Bobak R. Mozayeni - Rockville MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
International Classification:
B01D 6308
US Classification:
435311
Abstract:
An apparatus and process for continuous, cell-free, in vitro synthesis of peptides, particularly peptide-MHC complexes make use of a novel bioreactor flow cell which allows for the reproducible, systematic variation of single parameters in order to optimize translation processes. The bioreactor flow cell includes a pair of substantially parallel membranes positioned within a chamber to define therebetween a space, the ratio of total membrane surface area to chamber volume being at least 5 units. sup. -1, which permits high perfusion rates through the system with lower flux rate per membrane area. The apparatus also may include a novel countercurrent flow dialysis cell and other components.